Fixed Order, Open-Label, Dose-Escalation Study of DMT in Humans

• Status: Recruiting
• Trial end date: 2022-06-01
• Target enrollment: 0
• Participant gender: All

Summary

The goal of this fixed order, open-label, dose-escalation study is to investigate the safety and efficacy of specific doses of dimethyltryptamine (DMT) in humans.

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Yale University
• Treatments: N,N-Dimethyltryptamine

Criteria

Healthy controls inclusion criteria:

• Medically healthy

• Psychiatrically healthy

Healthy controls exclusion criteria:

• Unstable medical conditions

• Psychiatric illness

Depression inclusion criteria:

• Medically healthy

• Diagnosis of major depressive disorder

Depression exclusion criteria:

-Unstable medical conditions